Sponsored content: From time to time CVN publishes content sponsored by partners who offer services we believe are of interest to our subscribers.
In September 2019, a New Jersey jury returned a $37.2 million verdict for four plaintiffs claiming they developed mesothelioma from asbestos supposedly present in Johnson & Johnson's cosmetic talc products. The following January, a new jury convened to consider claims for punitive damages in a second trial that included in-person testimony from J&J CEO Alex Gorsky for the first time at a cosmetic talc trial.
Jurors returned a $750 million verdict, and here Courtroom View Network breaks down the most crucial parts of the 12-day trial into a single 20-minute video.
Thanks to our partner, ChartSquad, you can access this curated clip for FREE - usually only available to CVN Essentials subscribers - simply by filling out the form on our website.